The Funding of Biopharmaceutical Research and Development, 1st Edition

  • Published By:
  • ISBN-10: 1908818387
  • ISBN-13: 9781908818386
  • DDC: 615.7
  • Grade Level Range: College Freshman - College Senior
  • 284 Pages | eBook
  • Original Copyright 2013 | Published/Released June 2014
  • This publication's content originally published in print form: 2013

  • Price:  Sign in for price



The funding of Biopharmaceutical Research and Development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceutical market. It addresses private and public funding sources available in the US and internationally. The biopharmaceutical market is among the most research-intensive market sectors globally. Clinical researchers face a multitude of public and private funding options in going to market. These funding options are continually changing and complex and are expected to decrease in the near future. A lack of understanding of the scale, scope, and inner workings of R&D funding can, at times, act as a barrier and slow down or even eliminate the R&D process. The book lessens these barriers by describing the theoretical underpinnings, present practice, and trends in R&D funding in the US and internationally. It includes a review and discussion of public-private partnership activity, noting the complementary relationship between public and private funding. The book also contains an overview of the inner-workings of strategic alliance activity, including advantages and disadvantages for each party. It provides an outline of venture capital activity, detailing methods by which venture capital firms raise capital and are organized and a description of the venture capital-entrepreneur arrangement and its effects. The book also presents an overview of the IPO process and the fates of firms going public.

Table of Contents

Front Cover.
Half Title Page.
Other Frontmatter.
Title Page.
Copyright Page.
Dedication Page.
List of Figures and Tables.
About the Author.
1: Introduction to the Biopharmaceutical Market.
2: Synopsis of Theories of the Firm and Valuation Methods.
3: Innovation and the Merging of the Pharmaceutical and Biotechnology Industries.
4: The Funding of Basic Research and Public–Private Partnerships.
5: Strategic Alliances.
6: Angel and Venture Capital.
7: The Initial Public Offering.
8: Conclusion.